Patient in Focus works closely, both abroad and at home with a number of organizations, authorities, the pharmaceutical industry and patient associations.
Patient in Focus is registered with the European Commission and can participate in research projects throughout Europe.
Patient in Focus may include direct and indirect industry support but is independent of this support. The pharmaceutical industry does not sit on the Board of Patient in Focus and has no influence on the organization. Patient in Focus is compatible with foundation support with established criteria for openness and independence. If Patient in Focus receives more than five percent, it enters into a dialogue with the board’s committee with a view to assessing the project’s openness.